Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Not Lagging Market On Growth Or Pricing

With a price-to-earnings (or "P/E") ratio of 36.2x Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) may be sending very bearish signals at the moment, given that almost half of all companies in Saudi Arabia have P/E ratios under 20x and even P/E's lower than 14x are not unusual. Although, it's not wise to just take the P/E at face value as there may be an explanation why it's so lofty.

Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit.

There hasn't been much to differentiate Dr. Sulaiman Al Habib Medical Services Group's and the market's earnings growth lately. One possibility is that the P/E is high because investors think this modest earnings performance will accelerate. If not, then existing shareholders may be a little nervous about the viability of the share price.

See our latest analysis for Dr. Sulaiman Al Habib Medical Services Group

Keen to find out how analysts think Dr. Sulaiman Al Habib Medical Services Group's future stacks up against the industry? In that case, our free report is a great place to start.

How Is Dr. Sulaiman Al Habib Medical Services Group's Growth Trending?

In order to justify its P/E ratio, Dr. Sulaiman Al Habib Medical Services Group would need to produce outstanding growth well in excess of the market.

Taking a look back first, we see that the company managed to grow earnings per share by a handy 10% last year. The latest three year period has also seen an excellent 60% overall rise in EPS, aided somewhat by its short-term performance. Accordingly, shareholders would have probably welcomed those medium-term rates of earnings growth.

Shifting to the future, estimates from the eleven analysts covering the company suggest earnings should grow by 18% per annum over the next three years. Meanwhile, the rest of the market is forecast to only expand by 12% each year, which is noticeably less attractive.

With this information, we can see why Dr. Sulaiman Al Habib Medical Services Group is trading at such a high P/E compared to the market. Apparently shareholders aren't keen to offload something that is potentially eyeing a more prosperous future.

The Final Word

Using the price-to-earnings ratio alone to determine if you should sell your stock isn't sensible, however it can be a practical guide to the company's future prospects.

We've established that Dr. Sulaiman Al Habib Medical Services Group maintains its high P/E on the strength of its forecast growth being higher than the wider market, as expected. Right now shareholders are comfortable with the P/E as they are quite confident future earnings aren't under threat. Unless these conditions change, they will continue to provide strong support to the share price.

Having said that, be aware Dr. Sulaiman Al Habib Medical Services Group is showing 3 warning signs in our investment analysis, and 1 of those is significant.

If you're unsure about the strength of Dr. Sulaiman Al Habib Medical Services Group's business, why not explore our interactive list of stocks with solid business fundamentals for some other companies you may have missed.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.